全球esketamine市场规模（按类型、应用、地区、范围和预测）

esketamine市场规模与预测

2024 年esketamine市场规模价值为 15.4 亿美元，预计 2032 年将达到 25 亿美元，2026 年至 2032 年的复合年增长率为 6.23%。

市场的主要驱动因素包括患者数量的增加、病情认识水平的提高、标准药物治疗缺乏效率和安全性以及限制因素、技术先进的医疗保健基础设施的发展、与国际大学和知名供应商合作开展的有效esketamine的开发研究计划。本研究报告对esketamine市场进行了全面的评估，包括关键细分市场、趋势、市场驱动因素、限制因素、竞争格局以及在市场中发挥重要作用的因素。

定义全球esketamine市场

esketamine，以 Ketanest 等品牌出售，是一种用于全身麻醉剂和抗治疗性忧郁症的药物。esketamine可透过静脉注射或滴鼻剂给药。esketamine通常作为非竞争性 N-甲基-D-天冬胺酸受体拮抗剂发挥作用。

过去二十年，esketamine市场规模快速成长，同时，企业结构和员工行为模式也发生了变化，带来了许多挑战。全球esketamine市场正在经历重大变革，製造商需要不断创新才能维持其工作结构。

全球esketamine市场概览

推动esketamine市场发展的因素包括：患者人数不断增加、对疾病状况的认知度不断提高、标准药物疗法缺乏有效性和安全性、药物动力学差异大、生物有效性低，以及易引起胃肠道反应和药物交互作用 (DDI)。esketamine市场的机会在于其可靠的血脑屏障绕过方法、多种治疗药物的非侵入性给药方式以及可触发的製剂。

预计刺激全球esketamine市场的主要因素包括：增加对多种预防性esketamine研发计画的投入，以及监管机构推出的物种健康相关指南。建造技术先进的医疗基础设施，并与国际大学和知名供应商合作开展有效esketamine研发计划，将为全球esketamine市场带来丰厚的成长机会。然而，全球市场仍面临挑战，因为全球很大一部分人口（主要是新兴经济体）尚未有效利用esketamine。

然而，该行业设施营运和维护的高成本预计将阻碍因素市场成长。此外，合格专业人员的短缺也是市场成长的挑战。非结构化资料过剩预计将减缓经济成长。电子元件互连日益复杂、全球大宗商品价格下跌以及近期新冠疫情的爆发，为esketamine市场带来了许多挑战。然而，在预测期内，网路需求、智慧医疗基础设施需求、医疗应用中的机器人技术以及基于感测器的设备的成长预计将为esketamine市场带来重大机会。

目录

第一章全球esketamine市场简介

• 市场概览
• 研究范围
• 先决条件

第二章执行摘要

第三章：已验证的市场研究调查方法

• 资料探勘
• 验证
• 第一手资料
• 资料来源列表

第四章全球esketamine市场展望

• 概述
• 市场动态
  • 驱动程式
  • 限制因素
  • 机会
• 波特五力模型
• 价值链分析

第五章 全球esketamine市场（按类型）

• 概述
• 口服药物
• 注射
• 滴鼻剂
• 其他的

第六章 全球esketamine市场（依应用）

• 概述
• 全身麻醉剂
• 抗治疗性忧郁症

第七章全球esketamine市场（按地区）

• 概述
• 北美洲
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 世界其他地区
  • 南美洲
  • 中东和非洲

第八章全球esketamine市场的竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第九章 公司简介

• Merck
• Medkoo
• Endo International
• Janssen Pharmaceutica
• PFIZER.

第十章 附录

• 相关调查

Esketamine Market Size And Forecast

Esketamine Market size was valued at USD 1.54 Billion in 2024 and is projected to reach USD 2.5 Billion by 2032, growing at a CAGR of 6.23% from 2026 to 2032.

Driving factors for the market are increased number of patients also Improved awareness level of disease state, lack of efficiency and safety of the standard pharmacological therapies and restraints, developing technologically advanced healthcare infrastructure, and ongoing research projects in association with international universities and prominent vendors for the development of effective esketamine. The Global Esketamine Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Esketamine Market Definition

Esketamine sold out under the brand name Ketanest among others, is a medication that is used as a general anesthetic and for treatment-resistant depression. Esketamine is used by putting injection into a vein or through a nasal spray. Esketamine acts generally as a non-competitive N-methyl-D-aspartate receptor antagonist.

Over the past two decades, the Esketamine Market has grown at an enormous scale, and over time it has brought many challenges with the change in the structure of the company and the way employees behave. The global Esketamine Market is undergoing significant changes, as the manufacturers need to evolve in an attempt to keep the structure of their work.

Global Esketamine Market Overview

Factors that drive Esketamine Market are the increased number of patients also Improved awareness level of disease state, lack of efficiency and safety of the standard pharmacological therapies and restraints for the following could be Pharmacokinetic variability, low bioavailability, and large propensity to cause gastrointestinal effects and DDI and the opportunities for Esketamine Market could be that it is a reliable method to bypass the BBB, non-invasive delivery of a wide range of therapeutic agents, Triggerable formulations.

Increasing investment in R&D programs for the development of several preventive Esketamine and guidelines provided by regulatory bodies associated with species health are the major factors expected to stimulate the global Esketamine Market. Developing technologically advanced healthcare infrastructure and ongoing research projects in association with international universities and prominent vendors for the development of effective Esketamine will provide lucrative growth opportunities to the global Esketamine Market. However, the global market faces challenges as a large percentage of the global population predominantly in developing economies is yet to efficiently utilize them.

However, the high costs associated with the operation and maintenance of facilities in the sector will be a hindrance to the growth of the market. In addition, the lack of qualified specialists will challenge the growth of the market. Excess of unstructured data is expected to slow economic growth. The increasing complexity of interconnecting electronic components, the drop in global commodity prices, and the recent outbreak of COVID-19 have brought up many challenges to Esketamine Market. Nevertheless, rising demand for networking, demand for smart healthcare infrastructure, robotics in healthcare applications, and sensor-based devices are expected to provide huge opportunities for the Esketamine Market for the forecasted period.

Global Esketamine Market Segmentation Analysis

The Global Esketamine Market is Segmented on the basis of Type, Application, And Geography.

Esketamine Market, By Type

• Oral Medications
• Injection
• Nasal Spray
• Others

Based on Type, the market is bifurcated into Oral Medications, Injection, Nasal Spray, and Others. Oral Medication dominated the global market in 2020 owing to its raw material abundance and is expected to continue the trend in the forecast period.

Esketamine Market, By Application

• General Anesthetic
• Treatment-resistant Depression

Based on Application, the market is bifurcated into General Anesthetic and Treatment-resistant Depression. General anesthesia is a condition of controlled unconsciousness. During general anesthesia, medications are used to send a patient to sleep, so patients do not know about the surgery and do not move or feel pain during the procedure.

Esketamine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the Global Esketamine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The North American region dominated the global market in 2020 owing to a large number of manufactures available in the region followed by Europe and is expected to continue the trend in the forecast period. The Asia Pacific region is expected to grow at a rapid pace in the forecast period owing to rapid urbanization and industrialization with an increased investment towards smart & efficient technology and increased per capita income.

Key Players

The "Global Esketamine Market" study report will provide a valuable insight with an emphasis on the global market including some of the major players such as Merck, Medkoo, Endo International, Janssen Pharmaceutica, and PFIZER.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL ESKETAMINE MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL ESKETAMINE MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL ESKETAMINE MARKET, BY TYPE

• 5.1 Overview
• 5.2 Oral Medications
• 5.3 Injection
• 5.4 Nasal Spray
• 5.5 Others

6 GLOBAL ESKETAMINE MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 General Anesthetic
• 6.3 Treatment-resistant Depression

7 GLOBAL ESKETAMINE MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 South America
  • 7.5.2 Middle East and Africa

8 GLOBAL ESKETAMINE MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Merck
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Medkoo
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Endo International
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 Janssen Pharmaceutica
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 PFIZER.
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments

10 Appendix

• 10.1 Related Research